Target intelligence / Profile preview

ribosomal protein S17 pseudogene 14 (RPS17P14)

Target: RPS17P14
Molecular classification: Other (processed pseudogene)

Overview

ribosomal protein S17 pseudogene 14 (RPS17P14) is a non-coding processed pseudogene in humans. It arises from duplication and genomic dispersion of the functional ribosomal protein S17 gene (RPS17), which codes for a component of the cytoplasmic 40S ribosomal subunit. Unlike RPS17, RPS17P14 does not code for an active protein, is not expressed, and has no known biological or disease relevance. Multiple pseudogenes of ribosomal proteins exist throughout the genome, and their annotation can lead to confusion when extracting gene lists or drug targets; however, pseudogenes like RPS17P14 are not considered therapeutic or functional molecular targets[2][5].

Other names: RPS17_6_941RPS17P14

Beyond the preview

Go deeper on ribosomal protein S17 pseudogene 14 (RPS17P14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein S17 pseudogene 14 (RPS17P14).

Explore the full profile